Indication
Clostridioides difficile infection
Clostridioides difficile infection is a bacterial disease of the gastrointestinal tract caused by the toxin-producing, spore-forming anaerobic bacterium *Clostridioides difficile* (formerly *Clostridium difficile*). Read more about Clostridioides difficile infection
70 drugs 55 manufacturers
Drugs that treat it
Common Clostridioides difficile infection therapies.
VANCOMYCIN HCL-0.9% NACL (vancomycin in 0.9 % sodium chloride)
VANCOMYCIN HCL
VANCOMYCIN HCL
VANCOMYCIN HCL
VANCOMYCIN HCL
VANCOMYCIN HCL
VANCOMYCIN HCL
VANCOMYCIN HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonClostridioides difficile infection is a bacterial disease of the gastrointestinal tract caused by the toxin-producing, spore-forming anaerobic bacterium *Clostridioides difficile* (formerly *Clostridium difficile*).
It most commonly affects adults with recent broad-spectrum antimicrobial exposure, advanced age, or prolonged healthcare facility contact, where disruption of the normal colonic microbiota permits bacterial spore germination and overgrowth.
Pathogenesis is primarily mediated by bacterial exotoxins (toxin A and toxin B) that damage the intestinal mucosal epithelium, induce intense localized inflammation, and alter fluid secretion.
Clinical manifestations range from mild watery diarrhea, abdominal cramping, and leukocytosis to life-threatening complications such as pseudomembranous colitis, toxic megacolon, bowel perforation, sepsis, and shock.
- nih.gov
Clostridioides difficile infection is a bacterial disease of the gastrointestinal tract caused by the toxin-producing, spore-forming anaerobic bacterium *Clostridioides difficile* (formerly *Clostridium difficile*) It most commonly affects adults with recent broad-spectrum antimicrobial exposure, advanced age, or prolonged healthcare facility contact, where disruption of the normal colonic microbiota permits bacterial spore germination and overgrowth Clinical manifestations range from mild water...
- cdc.gov
Clostridioides difficile infection is a bacterial disease of the gastrointestinal tract caused by the toxin-producing, spore-forming anaerobic bacterium *Clostridioides difficile* (formerly *Clostridium difficile*) Pathogenesis is primarily mediated by bacterial exotoxins (toxin A and toxin B) that damage the intestinal mucosal epithelium, induce intense localized inflammation, and alter fluid secretion
- nih.gov
It most commonly affects adults with recent broad-spectrum antimicrobial exposure, advanced age, or prolonged healthcare facility contact, where disruption of the normal colonic microbiota permits bacterial spore germination and overgrowth Pathogenesis is primarily mediated by bacterial exotoxins (toxin A and toxin B) that damage the intestinal mucosal epithelium, induce intense localized inflammation, and alter fluid secretion
- nih.gov
It most commonly affects adults with recent broad-spectrum antimicrobial exposure, advanced age, or prolonged healthcare facility contact, where disruption of the normal colonic microbiota permits bacterial spore germination and overgrowth
- nih.gov
Pathogenesis is primarily mediated by bacterial exotoxins (toxin A and toxin B) that damage the intestinal mucosal epithelium, induce intense localized inflammation, and alter fluid secretion
- cdc.gov
Clinical manifestations range from mild watery diarrhea, abdominal cramping, and leukocytosis to life-threatening complications such as pseudomembranous colitis, toxic megacolon, bowel perforation, sepsis, and shock
Personalize your experience
Follow Clostridioides difficile infection and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.